Rapid Science Publishers are delighted to announce the forthcoming launch of Angiogenesis (ISSN: 0969-6970), an innovative journal with a strong international Editorial Board. The Journal will be published bimonthly with six issues per year. It will emphasise the need to encourage active research towards the development of practical therapies against angiogenic diseases.

Angiogenesis will be devoted to the rapid publication in both print form and on the World-Wide-Web, of experimental and clinically-orientated research focusing on the following areas:

  • the role of angiogenesis in tumour biology, wound healing and chronic inflammation and its importance in cardiology, opthalmology and other diseases. These will include tumour progression and metastasis, arthritis, psoriasis, atherosclerosis, myocardial infarction, diabetic retinopathy, macular degeneration, hemangioma and Kaposi's sarcoma

  • mechanisms controlling angiogenesis under physiological (eg. endometrial angiogenesis) and pathological conditions (eg. atherosclerosis and cancer)

  • endogenous endothelial growth factors, angiogenesis inhibitors, cellular adhesion molecules and extracellular matrix in angiogenesis cascade

  • the clinical development of potential drugs, antibodies and gene therapy to control angiogenic pathways

  • development of new markers and techniques for the assessment of angiogenic activity of potential prognostic and predictive value of tumour prognosis and response to antiangiogenic agents

We are very pleased to announce that the Editor-in-Chief is Dr Tai-Ping Fan of Department of Pharmacology, University of Cambridge, UK.
The Associate Editors are: Roy Bicknell, Imperial Cancer Research Fund, Oxford, UK, Judah Folkman, Harvard Medical School, Boston, USA, James Pluda, National Cancer Institute, Bethesda, USA and Peter Polverini, University of Michigan, MI, USA.


The Editors invite the submission of articles on the above subjects areas in the form of Original Papers, Reviews, Brief Communications, Letters to the Editor, Editorials and Commentaries. Please refer to the instructions for authors for details of how and to whom manuscripts for consideration should be sent.


To reflect the rapid advances in angiogenesis research, our main emphasis will be on speed of publication. All accepted articles will be published initially on the Internet and appear in the printed version of the Journal within 12 weeks of receipt of accepted papers.

There are no page or administration charges for papers published in the journal.

chapman and hall